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Özet
Amaç: Yardımcı üreme tekniklerinde gözlenen büyük gelişmelerin aksine kli-
nik gebelik elde etme oranları taze embriyo transferlerinde %31, oosit do-
nasyonlarında ise %41 düzeylerinde kalmıştır. İmplantasyon penceresi de-
nilen dönem ve implantasyonun kendisi in-vitro fertilizasyon uygulamasında 
önemli bir yere sahiptir. Bu çalışma ile tekrarlayan implantasyon başarısızlığı 
olan in-vitro fertilizasyon hastalarında CD56 ve CD98 in immunohistokimya-
sal olarak boyanmasındaki farklar incelenmek istenmiştir. Gereç ve Yöntem: 
Bu çalışma 2004 ile 2010 yılları arasında in-vitro fertilizasyon yöntemi uygu-
lanan 6260 hasta verisinin bulunduğu bir veribankasından tarama ile seçilen 
36 hastanın örneklerinin değerlendirilmesi ile yapılmıştır. Tekrarlayan imp-
lantasyon başarısızlığı en az 3 kez in-vitro fertilizasyon denemesi yapılma-
sı ve toplamda 8 embriyo verilmesini takiben b-HCG testinin pozitifleşmeme-
si olarak tanımlanmıştır. Diğer yanda kontrol grubunda ise ilk in-vitro ferti-
lizasyon denemelerinde b-HCG testinin pozitifleştiği hasta grubu bulunmak-
tadır. Bulgular: Yapılan karşılaştırmada CD 56 ve CD 98 boyanma yüzdeleri, 
boyanma gücü ve boyanma skoları arasında gruplar arasında anlamlı farklar 
saptanmıştır. (p<.001). Tekrarlayan implantasyon başarısızlığı olan hastala-
rın endometriyal örneklerinde CD 98 boyanması kontrol grubuna gore anlam-
lı olarak daha azdır. Tartışma: CD 56 ve CD 98 in immunohistokimyasal ola-
rak boyanmaları in-vitro fertilizasyon tedavisi uygulanacak olan hastalarda 
tanısal testlerin parçaları olabilirler. Bu markırların gebelik oluşumu ve gebe-
lik sürecine olan genel etkilerinin araştırılması açısından daha ileri araştırma-
lara gerek duyulmaktadır. 
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Abstract
Aim: Despite major advances in assisted reproductive techniques, clinical 
pregnancy rates remain around 31% with fresh embryo transfer and around 
41% with oocyte donations. We also know that the implantation process it-
self and the window period defined as the ‘’implantation phase’’ are signifi-
cantly important for successful in-vitro fertilization (IVF) cycles.  With this 
study we have tried to determine any differences in immunohistochemical 
staining for CD56 and CD98 within the implantation phase endometrium of 
patients with recurrent implantation failure and of a control group that even-
tually had a successful IVF cycle. Material and Method: This study was ret-
rospectively performed on a total of 36 patients selected out of a database 
of 6260 patients who received their IVF cycles from 2004 to 2010. Patients 
were defined as implantation failure if they did not have a positive result for 
b-HCG testing following at least 3 IVF cycles with a total of at least 8 em-
bryo transfers. The control group was formed with patients who had success 
(positive b-HCG testing) on their first IVF treatment. Results: Comparison 
of means for CD 56 staining percentages, CD 98 staining percentages, CD 
98 staining power, and CD 98 staining score showed significant difference 
between the control group and the study group (p<.001). The endometrium of 
patients without recurrent implantation failure is significantly more stainable 
by CD 98 than that of patients with recurrent implantation failure. Discus-
sion: We suggest that CD 56 and CD 98 staining for endometrium tissue 
can be a part of diagnostic testing for patients who are candidates for IVF 
treatments. We need further studies to determine the correlation between 
the overall chance for pregnancy and these types of immunohistochemical 
staining for patients receiving IVF treatment.
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Introduction
Implantation is one of the most important parts of the whole 
process that lies beneath the miraculous event of pregnancy. 
Implantation is a limiting factor for both natural (unassisted) 
female reproduction and in-vitro fertilization (IVF) cycles. De-
spite major advances in assisted reproductive techniques, 
clinical pregnancy rates remain around 31% with fresh embryo 
transfer and around 41% with oocyte donations [1].
CD 98 is a type II glycoprotein usually found in ovarian, testicu-
lar, and placental tissues. It also can be found in liver, renal, and 
splenic tissues, participating in the process of amino-acid and 
hormonal transport [2-3]. CD 98 expression, which is specific 
to the implantation phase for human reproduction, has a very 
important role. It was determined that rats with suppressed CD 
98 expression with lent viruses showed a diminished blasto-
cyst adhesion. Conversely, increasing CD 98 expression by 2-10 
times showed an implantation rate up to 100% [4].
CD 56 positive cells, known as natural killer cells, have been 
studied extensively to understand their role in both implanta-
tion failure and recurrent miscarriages. The principal finding 
has been elevated numbers of CD 56 + cells in the endometrium 
of women with implantation failure and recurrent miscarriage 
compared to control groups [5-7].
As we know, many factors play a role in implantation failure. 
With this study we have tried to identify any differences of im-
munohistochemical staining for CD56 and CD98 within the im-
plantation phase in the endometrium of patients with recurrent 
implantation failure and in the control group who eventually 
had a successful IVF cycle.
Material and Method
This study was performed retrospectively on a total of 36 pa-
tients selected out of a database of 6260 patients who had 
their IVF cycles between 2004 and 2010. 936 patients were 
categorized as implantation failure, which was defined as fail-
ure to have a positive result for b-HCG testing following at least 
3 IVF cycles with a total of at least 8 embryo transfers. Note 
that the IVF treatments of the patients selected for this study 
occurred before the national law limiting the number of em-
bryos that may be transferred under different circumstances 
went into effect.  
Patient Selection
586 patients who did not have a hysteroscopy before their IVF 
cycle and 118 patients whose hysteroscopy revealed polyps, 
septum, or adhesions were excluded from the study. 41 patients 
with poor ovarian reserve, defined as the need for r-FSH more 
than 3000 units and/or patients with metaphase 2-oocyte count 
less than 6 in an IVF cycle, were also excluded.  Additionally, 78 
patients who were more than 37 years old were excluded due to 
advanced maternal age.  Of the remaining 113 patients, 67 had 
a specimen taken from the endometrium but only 21 had 5-10 
days post ovulatory characteristics defined by Noyes et al [8].
In selecting the control group, we retrospectively screened 
3738 patients who were not successful in having spontaneous 
pregnancy but had pregnancy over 12 weeks on IVF cycle fol-
lowing an endometrial biopsy collected during the luteal phase. 
Of these, 2789 patients were excluded because they did not 
have a hysteroscopy and 403 patients were excluded because 
of pathological findings in the hysteroscopy. 237 patients were 
excluded because of advanced maternal age and 117 were ex-
cluded for poor ovarian reserve.  15 out of the 192 remaining 
patients had specimens appropriate for the implantation phase 
(post ovulatory 5-10 days). 
Immunohistochemical Staining and Evaluation
5 μm samples were taken to Poly-L-Lysine covered microscopic 
slides from paraffin embedded original tissues. Following de-
paraffinization, ‘’Autostainer Link 48 (DAKO)’’ and as antibody 
(7.0ml, Ready to use, Code IR 628, Clone 123C3, DAKO, USA) 
used for staining procedure for CD 56.
Image 1 shows sample images for CD 56 staining. 
CD 98 staining was done with the biotin immuneperoxidase 
method using N1C2 (1/200 dilution, catalogue GTX 104108, 
Gene Text, Inc.) and incubated at +4°C overnight. 
Image 2 shows sample images for CD 98 staining.  
CD 56 antibody staining was scored from 0 to 4 according to 
the percentages of red-brown staining cell diffusiveness from 
0%, 1%-25%, 26%-50%, 51%-75%, and 76%-100%, respec-
tively.    
CD 98 antibody staining was evaluated for its staining power 
and diffusiveness. Diffusiveness was scored as it was for CD 
56 and the results were multiplied by a power score ranging 
from 1-3 as weak, moderate, or strong staining. The minimum 
score for CD 98 was 0 (no staining) and the maximum score 
was 12 (more than 75% and strong membranous staining). 
Stromal staining for CD 98 was recorded separately as positive 
or negative. 
Independent samples T test, one-way ANOVA, and chi-square 
statistical methods were used as appropriate. IBM SPSS 17.0 
was used for statistical analysis and a p value less than 0.05 
was accepted as statistically significant.
Ethics and Institutional Review Board Approval
Baskent University IRB approved this study; the approval num-
ber is KA11/120.
Results
The study group had a mean age of 31.9 ± 2.7, whereas the 
control group had a mean age of 28.5 ± 3.5 (p=.002). Table 1 
compares other IVF cycle parameters.
Comparison of means for CD 56 staining percentages, CD 98 
staining percentages, CD 98 staining power, and CD 98 staining 
scores showed significant difference between groups (p<.001) 
(Table 2).
There were significant differences between subgroup results of 
CD 56 staining percentages, CD 98 staining power, and CD 98 
staining percentages. No significant difference was observed 
in CD 98 stromal staining (Table 3). Using a scoring system 
that included both CD 98 staining percentage and CD 98 stain-
ing power (percentage value from 1-4 multiplied by power 
from 1-3), there was a significant difference between groups 
(p<0.05).
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Discussion
Knowing the limitations of retrospective studies, we excluded 
possibly important factors for implantation such as poor ovari-
an reserve, patients with anatomical uterine defects and patho-
logical findings, and advanced maternal age in order to improve 
the study quality. Also, the study and control groups had quite 
similar IVF cycle parameters, which contributed to comparabil-
ity of groups.
There are authors who propose that a similar pathogenesis lies 
beneath recurrent implantation failure and recurrent pregnancy 
losses. That is the reason given by most of the leading articles, 
mostly done by Quenby et al., for recurrent implantation failure 
was done with CD 56 [7,9]. While Quenby et al. propose that 
implantation failure relates to oxidative stress on endometrial 
tissue originating from endometrial edema formation, which 
is found with increased number of uNK cells and endometrial 
blood vessels [9]. On the other hand, Matteo et al. found no 
difference in CD 56 + cells between the recurrent implantation 
failure group and the control group in a study performed with 
the flow cytometry technique which also includes CD 56 + cells 
from blood vessels [10]. Our study showed that the presence of 
CD 56 + cells in endometrial stromal tissue can be a destructive 
element for embryo implantation. 
Although there is not sufficient published data to draw conclu-
sions about human endometrial tissue, animal studies showed 
the importance of CD 98 expressing cells for implantation and 
reproduction. We found that a decreased number of CD 98 ex-
pressing cells, resulting in decreased amino-acid and hormonal 
transportation in endometrial tissue, can be one of the factors 
for implantation failure.
We suggest that CD 56 and CD 98 staining for endometrium 
tissue can be a part of diagnostic testing for patients who are 
candidates for IVF treatments. We need further studies to de-
termine the correlation between the overall chance for preg-
nancy and these types of immunohistochemical staining for 
patients receiving IVF treatment. 
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Table 1. Comparison of different IVF parameters between groups. 
Study Group Control Group P value
Total Transferred Embryo 
Count
11.95 ± 3.81 2.80 ± 0.56 <.001
D3 FSH (mIU/mL) 5.97 ± 1.53 4.91 ± 1.21 .043
Antral Follicle Count 6.61 ± 2.50 7.7 ± 3.20 .299   
D5  E2 Level (pg/mL) 361.9 ± 222.1 420.4 ± 219.5 .453
HCG Day E2 Level (pg/mL) 1899.1 ± 1018.3 2114.3 ± 1007.1 .547
HCG Day Progesterone Level 
(ng/mL)
0.744 ± 0.53 0.671 ± 0.320 .635
HCG Day Endometrial Thick-
ness
11.02 ± 2.10 11.54 ± 2.80 .531
Salvaged Oocyte Count 15.4 ± 6.0 15.4 ± 6.6 .914
Metaphase II Oocyte Count 12.6 ± 4.9 12.4 ± 5.9 .905
Fertilization Rate 66.3 ± 20.1 73.7± 21.6 .302
Treatment Length (Days) 9.19 ± 1.60 8.40 ± 1.24 .495
Table 2. Comparison of staining power and percentages of CD 98 and CD 56
Study Group Control Group P Value
CD56 Staining Percentage 2.00 ± 0.77 1.20 ± 0.41 .001
CD98 Staining Percentage 2.33 ± 0.79 3.47 ± 0.64 <.001
CD98 Staining Power 1.57 ± 0.50 2.40 ± 0.50 <.001
CD98 Score 3.62  ± 1.53 8.20 ± 1.89 <.001
Table 3. Comparison of results within subgroups for CD 56 staining percent-
ages, CD 98 staining power and percentages.
Subgroups Study 
group
Control 
group
P value
CD56 Staining Percentage 1 (1-25%) 33.3% 80% .002*
2 (26-50%) 42.9% 20%
3 (51-75%) 28.6% 0%
CD98 Staining Power 1 42.9% 0% <.001*
2 57.1% 60%
3 0% 40%
CD98 Staining Percentage 1 (1-25%) 9.5% 0% <.001*
2 (26-50%) 57.1% 6.7%
3 (51-75%) 23.8% 40%
4 (76-100%) 9.5% 53.3%
CD98 Stromal Staining Positive 9.5% 20% .337
Negative 90.5% 80%
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